List of Tables
Table 1. Global Venous Thromboembolism Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Venous Thromboembolism Drug Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Venous Thromboembolism Drug Market Competitive Situation by Manufacturers in 2024
Table 4. Global Venous Thromboembolism Drug Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Venous Thromboembolism Drug Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Venous Thromboembolism Drug Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Venous Thromboembolism Drug Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Venous Thromboembolism Drug Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Venous Thromboembolism Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Venous Thromboembolism Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Venous Thromboembolism Drug, Product Type & Application
Table 12. Global Key Manufacturers of Venous Thromboembolism Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Venous Thromboembolism Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Venous Thromboembolism Drug as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Venous Thromboembolism Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Venous Thromboembolism Drug Sales by Region (2020-2025) & (K Units)
Table 18. Global Venous Thromboembolism Drug Sales Market Share by Region (2020-2025)
Table 19. Global Venous Thromboembolism Drug Sales by Region (2026-2031) & (K Units)
Table 20. Global Venous Thromboembolism Drug Sales Market Share by Region (2026-2031)
Table 21. Global Venous Thromboembolism Drug Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Venous Thromboembolism Drug Revenue Market Share by Region (2020-2025)
Table 23. Global Venous Thromboembolism Drug Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Venous Thromboembolism Drug Revenue Market Share by Region (2026-2031)
Table 25. North America Venous Thromboembolism Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Venous Thromboembolism Drug Sales by Country (2020-2025) & (K Units)
Table 27. North America Venous Thromboembolism Drug Sales by Country (2026-2031) & (K Units)
Table 28. North America Venous Thromboembolism Drug Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Venous Thromboembolism Drug Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Venous Thromboembolism Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Venous Thromboembolism Drug Sales by Country (2020-2025) & (K Units)
Table 32. Europe Venous Thromboembolism Drug Sales by Country (2026-2031) & (K Units)
Table 33. Europe Venous Thromboembolism Drug Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Venous Thromboembolism Drug Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Venous Thromboembolism Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Venous Thromboembolism Drug Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Venous Thromboembolism Drug Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Venous Thromboembolism Drug Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Venous Thromboembolism Drug Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Venous Thromboembolism Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Venous Thromboembolism Drug Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Venous Thromboembolism Drug Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Venous Thromboembolism Drug Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Venous Thromboembolism Drug Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Venous Thromboembolism Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Venous Thromboembolism Drug Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Venous Thromboembolism Drug Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Venous Thromboembolism Drug Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Venous Thromboembolism Drug Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Venous Thromboembolism Drug Sales (K Units) by Type (2020-2025)
Table 51. Global Venous Thromboembolism Drug Sales (K Units) by Type (2026-2031)
Table 52. Global Venous Thromboembolism Drug Sales Market Share by Type (2020-2025)
Table 53. Global Venous Thromboembolism Drug Sales Market Share by Type (2026-2031)
Table 54. Global Venous Thromboembolism Drug Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Venous Thromboembolism Drug Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Venous Thromboembolism Drug Revenue Market Share by Type (2020-2025)
Table 57. Global Venous Thromboembolism Drug Revenue Market Share by Type (2026-2031)
Table 58. Global Venous Thromboembolism Drug Price (US$/Unit) by Type (2020-2025)
Table 59. Global Venous Thromboembolism Drug Price (US$/Unit) by Type (2026-2031)
Table 60. Global Venous Thromboembolism Drug Sales (K Units) by Application (2020-2025)
Table 61. Global Venous Thromboembolism Drug Sales (K Units) by Application (2026-2031)
Table 62. Global Venous Thromboembolism Drug Sales Market Share by Application (2020-2025)
Table 63. Global Venous Thromboembolism Drug Sales Market Share by Application (2026-2031)
Table 64. Global Venous Thromboembolism Drug Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Venous Thromboembolism Drug Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Venous Thromboembolism Drug Revenue Market Share by Application (2020-2025)
Table 67. Global Venous Thromboembolism Drug Revenue Market Share by Application (2026-2031)
Table 68. Global Venous Thromboembolism Drug Price (US$/Unit) by Application (2020-2025)
Table 69. Global Venous Thromboembolism Drug Price (US$/Unit) by Application (2026-2031)
Table 70. Bayer Company Information
Table 71. Bayer Description and Business Overview
Table 72. Bayer Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Bayer Venous Thromboembolism Drug Product
Table 74. Bayer Recent Developments/Updates
Table 75. BMS Company Information
Table 76. BMS Description and Business Overview
Table 77. BMS Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. BMS Venous Thromboembolism Drug Product
Table 79. BMS Recent Developments/Updates
Table 80. Boehringer Ingelheim Company Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Boehringer Ingelheim Venous Thromboembolism Drug Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Daiichi Sankyo Company Information
Table 86. Daiichi Sankyo Description and Business Overview
Table 87. Daiichi Sankyo Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Daiichi Sankyo Venous Thromboembolism Drug Product
Table 89. Daiichi Sankyo Recent Developments/Updates
Table 90. J&J Company Information
Table 91. J&J Description and Business Overview
Table 92. J&J Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. J&J Venous Thromboembolism Drug Product
Table 94. J&J Recent Developments/Updates
Table 95. Sanofi Company Information
Table 96. Sanofi Description and Business Overview
Table 97. Sanofi Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Sanofi Venous Thromboembolism Drug Product
Table 99. Sanofi Recent Developments/Updates
Table 100. Altor Bioscience Company Information
Table 101. Altor Bioscience Description and Business Overview
Table 102. Altor Bioscience Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Altor Bioscience Venous Thromboembolism Drug Product
Table 104. Altor Bioscience Recent Developments/Updates
Table 105. Armetheon Company Information
Table 106. Armetheon Description and Business Overview
Table 107. Armetheon Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Armetheon Venous Thromboembolism Drug Product
Table 109. Armetheon Recent Developments/Updates
Table 110. Aspen Pharma Company Information
Table 111. Aspen Pharma Description and Business Overview
Table 112. Aspen Pharma Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Aspen Pharma Venous Thromboembolism Drug Product
Table 114. Aspen Pharma Recent Developments/Updates
Table 115. BioInvent Company Information
Table 116. BioInvent Description and Business Overview
Table 117. BioInvent Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. BioInvent Venous Thromboembolism Drug Product
Table 119. BioInvent Recent Developments/Updates
Table 120. eXIthera Pharmaceuticals Company Information
Table 121. eXIthera Pharmaceuticals Description and Business Overview
Table 122. eXIthera Pharmaceuticals Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. eXIthera Pharmaceuticals Venous Thromboembolism Drug Product
Table 124. eXIthera Pharmaceuticals Recent Developments/Updates
Table 125. Gamma Therapeutics Company Information
Table 126. Gamma Therapeutics Description and Business Overview
Table 127. Gamma Therapeutics Venous Thromboembolism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Gamma Therapeutics Venous Thromboembolism Drug Product
Table 129. Gamma Therapeutics Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Venous Thromboembolism Drug Distributors List
Table 133. Venous Thromboembolism Drug Customers List
Table 134. Venous Thromboembolism Drug Market Trends
Table 135. Venous Thromboembolism Drug Market Drivers
Table 136. Venous Thromboembolism Drug Market Challenges
Table 137. Venous Thromboembolism Drug Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Venous Thromboembolism Drug
Figure 2. Global Venous Thromboembolism Drug Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Venous Thromboembolism Drug Market Share by Type: 2024 & 2031
Figure 4. Heparin Product Picture
Figure 5. Apixaban Product Picture
Figure 6. Dabigatran Product Picture
Figure 7. Rivaroxaban Product Picture
Figure 8. Edaxaban Product Picture
Figure 9. Warfarin Product Picture
Figure 10. Global Venous Thromboembolism Drug Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Venous Thromboembolism Drug Market Share by Application: 2024 & 2031
Figure 12. Hospital
Figure 13. Clinic
Figure 14. Global Venous Thromboembolism Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Venous Thromboembolism Drug Market Size (2020-2031) & (US$ Million)
Figure 16. Global Venous Thromboembolism Drug Sales (2020-2031) & (K Units)
Figure 17. Global Venous Thromboembolism Drug Average Price (US$/Unit) & (2020-2031)
Figure 18. Venous Thromboembolism Drug Report Years Considered
Figure 19. Venous Thromboembolism Drug Sales Share by Manufacturers in 2024
Figure 20. Global Venous Thromboembolism Drug Revenue Share by Manufacturers in 2024
Figure 21. Global 5 and 10 Largest Venous Thromboembolism Drug Players: Market Share by Revenue in Venous Thromboembolism Drug in 2024
Figure 22. Venous Thromboembolism Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Global Venous Thromboembolism Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 24. North America Venous Thromboembolism Drug Sales Market Share by Country (2020-2031)
Figure 25. North America Venous Thromboembolism Drug Revenue Market Share by Country (2020-2031)
Figure 26. United States Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. Canada Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Europe Venous Thromboembolism Drug Sales Market Share by Country (2020-2031)
Figure 29. Europe Venous Thromboembolism Drug Revenue Market Share by Country (2020-2031)
Figure 30. Germany Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. France Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. U.K. Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Italy Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. Russia Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Asia Pacific Venous Thromboembolism Drug Sales Market Share by Region (2020-2031)
Figure 36. Asia Pacific Venous Thromboembolism Drug Revenue Market Share by Region (2020-2031)
Figure 37. China Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Japan Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. South Korea Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. India Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Australia Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. China Taiwan Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Indonesia Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Thailand Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Malaysia Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Venous Thromboembolism Drug Sales Market Share by Country (2020-2031)
Figure 47. Latin America Venous Thromboembolism Drug Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Venous Thromboembolism Drug Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Venous Thromboembolism Drug Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Venous Thromboembolism Drug Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Venous Thromboembolism Drug by Type (2020-2031)
Figure 57. Global Revenue Market Share of Venous Thromboembolism Drug by Type (2020-2031)
Figure 58. Global Venous Thromboembolism Drug Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Venous Thromboembolism Drug by Application (2020-2031)
Figure 60. Global Revenue Market Share of Venous Thromboembolism Drug by Application (2020-2031)
Figure 61. Global Venous Thromboembolism Drug Price (US$/Unit) by Application (2020-2031)
Figure 62. Venous Thromboembolism Drug Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
